Search Results for "Orthophoenix Llc Medtornic Kyphon Patents"

22:02 EDT 1st September 2014 | BioPortfolio

Original Source: Orthophoenix created to acquire {Kyphon} patents

Recently created Orthophoenix LLC, made up of a consortium of investors experienced in medical devices, has acquired from [Medtronic Inc.]’s interventional spine division [Medtronic Sofamor Danek USA Inc.] approximately 500 patents and applications...

Matching Channels

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Tumor Necrosis Factor TNF Products

Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...

Coagulation Factors

Fourteen different blood coagulation factors are present in the body. Each plays a crucial role in the process described above. Some work to increase the activity level of the other factors while so...

Matching News

Thomas Whitelaw Wins $15.4M Verdict for Pabban Development

Closely-Watched Case Against Medtronic Affiliate Kyphon Sàrl Results in Complete Victory, Including Defense of $17M Counterclaims Thomas Whitelaw, a premier national litigati...

Genticel granted five new patents in the US and Asia during first half of 2014

Genticel has been granted five patents in major territories since the beginning of 2014. These patents consolidate Genticel’s product pipeline in important emerging and mature pharmaceutical markets...

Ryogen awarded two patents directed to polynucleotide sequences

Ryogen, an R&D company focusing on polynucleotide sequences implicated in human diseases, was awarded two new patents this month, bringing the total number of its issued U.S. Patents to 32.

UPDATE 1-Auto industry files 18 pct more international patents in 2013

* Jump in patents reflects drive to lower exhaust emissions

Why We Need IPR for GMOs

At GMO Answers, we’ve received several questions about corporate intellectual property rights (IPR) and patents on GMO seeds, with many believing that patents hurt farmers by forcing them to purchas...

Quantum Materials acquires patents from Bayer Technology services

Quantum Materials acquires  five diverse sets of patent families from Bayer Technology Services. The patents acquired provide broad intellectual property protection for advances Quantum Materials has...

2 patents issued to computer-aided detection firm VuCOMP

VuCOMP has received a pair of patents covering its M-Vu CAD mammography system.  -More- 

Keryx gets two US patents for Zerenex covering orally administrable forms of Ferric Citrate

Keryx Biopharmaceuticals has announced that the US Patent and Trademark Office has issued US Patents No. 8,754,257 and No. 8,754,258.

Matching PubMed Articles

Patents: a tool to bring innovation from the lab bench to the marketplace.

Intellectual property (IP) is creations of the mind. Protecting IP through patents is an important venue for a researcher to reap rewards from his scientific endeavors. It is part of a competitive str...

Reviews Of Acoustical Patents.

The purpose of these acoustical patent reviews is to provide enough information for a Journal reader to decide whether to seek more information from the patent itself. Any opinions expressed here are ...

Dendritic Cell Vaccine and Cancer Treatment: New Patents.

Dendritic cell (DC) immunotherapy has been used to treat various types of tumors. Although already in use in clinical practice, the mechanisms through which it acts need clarification. In addition, th...

Filed and granted Indian Patents in dentistry from 2005-2009: A critical analysis and review.

Background: Patent policies have proved to be extremely important for several countries to develop. India has achieved its global status since 2005; a critical analysis of the patents at IPO will help...

Framing the patent troll debate.

The patent troll debate has reached a fevered pitch in the USA. This editorial seeks to frame the debate by pointing out the lack of clarity in defining patent trolls and their allegedly harmful actio...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement